165
Participants
Start Date
February 28, 2002
Primary Completion Date
October 31, 2004
Study Completion Date
October 31, 2004
Zonisamide
Odessa Medical University, Odesa
Semmelweis University Health Science Faculty, Budapest
Vilnius University Hospital, Vilnius
Kaunas Medical University Clinics, Kaunas
Upstate Clinical Research Center, Albany
Tallinn Children's Hospital, Tallinn
Tartu University Hospital, Tartu
Dent Neurological Institute, Orchard Park
Westmoreland Neurology Associates, Inc., Greensburg
St. Agnes Health Care, Inc., Baltimore
Blue Ridge Research Center, Roanoke
Epilepsy Institute of North Carolina, Winston-Salem
Neurology & Headache Specialist of Atlanta, LLC, Decatur
Kharkov State Medical University, Kharkiv
Institute of Neurology, Psychiatry, and Narcology of AMS Ukraine, Kharkiv
AMO Corporation, Tallahassee
Bay Neurological Institute, Panama City
Neurology Associates, Maitland
Florida Epilepsy & Seizure Disorder Center, PA, Tampa
Suncoast Neuroscience Associates, Inc., St. Petersburg
UAB Epilepsy Center, Birmingham
Neurology Clinic, P.C., Northport
North Alabama Neuroscience, Huntsville
Louisville Neuroscience Research Center, Louisville
River Hills Health Care, Cincinnati
University of Wisconsin, Madison
Southern Illinois University School of Medicine Dept. of Neurology, Springfield
The Comprehensive Epilepsy Care Center, Chesterfield
Neurology Clinic of San Antonio, San Antonio
Northridge Neurological Center, Northridge
Coordinated Clinical Research, San Diego
Neurology & Neurosurgery Associates of Tacoma, Inc. P.S., Tacoma
Epilepsy Center, Kiev
CNS Research, INC, East Providence
National Institute of Neurosurgery Epilepsy Center, Budapest
Eisai Inc.
INDUSTRY